Clinical trial
A Prospective, Multicenter Observational Trial Assessing the Safety and Efficacy of Gammanorm® in Autoimmune Diseases
NCT03656640 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Observational Trial Assessing the Safety and Efficacy of Gammanorm® in Autoimmune Diseases
- Lead sponsor
- Octapharma
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 23, 2016
- Completion date
- December 9, 2019
- Enrollment
- 60 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.